Chronic subdural hematoma (cSDH) is frequently encountered in neurosurgical practice. Apart from traditional treatment approaches, such as surgical intervention or medical management, middle meningeal ...
SUNNYVALE, Calif., July 28, 2025 /PRNewswire/ -- Embolx, a leader in advanced microcatheters for targeted embolization procedures, today announced the release of its next-generation Sniper G3 Balloon ...
(MENAFN- GlobeNewsWire - Nasdaq) Borvo Medical to showcase innovative EVACTM system at Society of Neurointerventional Surgery Annual Meeting MOUNTAIN VIEW, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- ...
- TRUFILL n-BCA is now indicated for embolization of the middle meningeal artery (MMA) for the treatment of symptomatic subacute and Chronic Subdural Hematoma (cSDH) as an adjunct to surgery. - ...
BARCELONA, Spain — A new randomized trial of embolization of the middle meningeal artery (EMMA) following surgery for chronic subdural hematoma showed striking results, with a major drop in hematoma ...
- TRUFILL n-BCA is now indicated for embolization of the middle meningeal artery (MMA) for the treatment of symptomatic subacute and Chronic Subdural Hematoma (cSDH) as an adjunct to surgery. - ...
Johnson & Johnson has secured an expanded indication from FDA for its TRUFILL n‑BCA Liquid Embolic System for embolization of the middle meningeal artery for the treatment of symptomatic subacute and ...